BC Platforms supports FinnGen program to tap unique gene pool to find the next breakthroughs in disease prevention, diagnosis and treatment
FinnGen is a unique study that has been launched in Finland. Program will deepen our understanding about the origins of diseases and their treatment. The FinnGen study plans to tap into 500 000 unique blood samples collected by a nation-wide network of Finnish biobanks. The study is expected to continue for six years, securing funding of 59M€.
BC Platforms is one of the technology vendors in the project and also financed by Tekes (the Finnish Funding Agency for Technology and Innovation, a part of Finnish Ministry of Employment and the Economy). With this funding BC Platforms has developed a data availability query, meta-analytics and analysis result browsing platform for FinnGen´s research use. All queries are based on aggregate data only. With this platform, researchers can search for subjects with wanted clinical and genomic profile, perform and browse initial analyses, and propose separate research projects to FinnGen. In addition, BC Platforms contributes to clinical end-point design process by providing database solution for browsing and managing end-point definitions, integrated to the main technology platform.